Functional Microbiomics Core
功能微生物组学核心
基本信息
- 批准号:10492098
- 负责人:
- 金额:$ 75.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:3xTg-AD mouseAdministrative SupplementAdoptedAgingAlzheimer&aposs DiseaseAreaAwardBehaviorBioinformaticsBiologicalBlood - brain barrier anatomyBreedingCenters of Research ExcellenceCore FacilityData AnalysesDedicationsDerivation procedureDevelopmentEdible PlantsEquipmentExtramural ActivitiesFee-for-Service PlansFosteringFundingFutureGenomicsGerm-FreeGnotobioticGoalsHistopathologyHousingImageIndividualInflammationInflammation MediatorsInfrastructureInstitutionJointsKnockout MiceLaboratoriesMentorsMethodologyMissionModelingMusNational Institute of General Medical SciencesPathogenesisPathogenicityPhasePlayProcessProtocols documentationResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesRibosomal DNARoleSamplingServicesSystemTechniquesTestingTissuesTrainingTraining and EducationTransgenic OrganismsTranslational ResearchUniversitiesWhole OrganismWorkanimal facilitycancer immunotherapyclinical translationexosomeexperimental studyimaging facilitiesin vivo imaging systeminnovationintravital microscopymetabolomicsmicrobiome researchmicrobiotamicroscopic imagingmorris water mazemouse modelmulti-photonnanoporenovelobject recognitionprogramsprotocol developmentsuccesssynthetic polymer Bioplextooltumor immunology
项目摘要
Project Summary/Abstract
In this Phase 2 of the Functional Microbiomics, Inflammation and Pathogenicity COBRE, the primary goal of the
Functional Microbiomics Core (FMC) is unchanged. We will sustain and enhance the well-established integrated
service center that functions as a critical resource for the Research Project Leaders (RPLs) as a priority, and
secondarily for all investigators of the Center. Since all new COBRE projects also utilize mouse models to explore
the inter-relationships between inflammation and pathogenesis, and the contribution of microbiota to this
process, our well-established germ-free and gnotobiotic mice facility (GMF) will continue to play a central role in
services provided by the FMC. We will continue to provide anaerobic culturing of mixed and/or mono bacterial
strains to facilitate the specific colonization of the germ-free mice. 16S ribosomal DNA will be profiled with the
in-house developed Oxford nanopore sequencing as well as PacBio-long read sequencing tools, and
bioinformatic support provided. Our most extensively used resource; multiplex-based analysis of inflammatory
mediators in biological samples, will continue to function using the Bio-Plex 200 (Bio-Rad) multiplex system. In
addition, several recent advances allow us to augment the services provided by the FMC. First, the recently
developed, highly successful rederivation service of transgenic and KO mouse models as germ-free, will greatly
expand the scope and utility of the GMF. Related to this service is the development of a new area of research
on the role of microbiota in Alzheimer’s Disease (AD) supported by an administrative supplement to the FMC
from NIA/NIGMS. The GMF has already rederived several AD mouse models. For this project, the FMC also
developed a suite of mouse behavior analysis models including the Morris Water Maze and Novel Object
Recognition tests. These services will support all future ageing related research at the center including a new
project on the role of edible-plant derived exosomes in restoring the integrity of the Blood Brain Barrier. We also
now include imaging support, in particular Multiphoton Intravital Microscopy for imaging of live tissue and an In
Vivo Imaging System (IVIS) for live mouse imaging. Besides functioning as a service center, another major goal
of the FMC is to promote the education and training of researchers, primarily the RPLs. The FMC will also interact
with other Core facilities at the University of Louisville, such as the Genomics, Metabolomics and Bioinformatics
core facilities established with the support of other highly successful COBRE/INBRE programs. In particular, the
newly funded Cancer Immunology and Immunotherapy COBRE-operated Functional Immunomics Core (FIC)
facility also directed by Dr. Bodduluri has several joint initiatives with the FMC including the establishment of a
histopathology service center. The FMC will work with these and other UofL resources in order to avoid
duplication of equipment, and to train individual investigators in specific protocols, foster innovative protocol
development and integrate analysis of data.
项目概要/摘要
在功能微生物组学、炎症和致病性 COBRE 的第二阶段中,
功能微生物组学核心 (FMC) 保持不变。我们将维持并加强完善的综合
服务中心作为研究项目负责人(RPL)的关键资源作为优先事项,以及
其次是中心的所有调查员。由于所有新的 COBRE 项目也利用小鼠模型来探索
炎症与发病机制之间的相互关系以及微生物群对此的贡献
过程中,我们完善的无菌和无菌小鼠设施 (GMF) 将继续在
FMC 提供的服务。我们将继续提供混合和/或单一细菌的厌氧培养
菌株以促进无菌小鼠的特异性定植。 16S 核糖体 DNA 将用
内部开发的Oxford纳米孔测序以及PacBio-long read测序工具,以及
提供生物信息支持。我们使用最广泛的资源;基于多重的炎症分析
生物样品中的介质将继续使用 Bio-Plex 200 (Bio-Rad) 多重系统发挥作用。在
此外,最近的一些进展使我们能够增强 FMC 提供的服务。首先,最近
开发出高度成功的无菌转基因和 KO 小鼠模型再衍生服务,将极大地促进
扩大转基因食品的范围和效用。与这项服务相关的是新研究领域的发展
关于微生物群在阿尔茨海默病 (AD) 中的作用,并得到 FMC 行政补充的支持
来自 NIA/NIGMS。 GMF已经重新衍生了几种AD小鼠模型。对于这个项目,FMC 还
开发了一套小鼠行为分析模型,包括 Morris Water Maze 和 Novel Object
识别测试。这些服务将支持该中心所有未来与老龄化相关的研究,包括一项新的研究
研究可食用植物来源的外泌体在恢复血脑屏障完整性中的作用的项目。我们也
现在包括成像支持,特别是用于活体组织成像的多光子活体显微镜和 In
用于活体小鼠成像的 Vivo 成像系统 (IVIS)。除了作为服务中心之外,另一个主要目标
FMC 的职责是促进研究人员(主要是 RPL)的教育和培训。 FMC还将互动
与路易斯维尔大学的其他核心设施合作,例如基因组学、代谢组学和生物信息学
核心设施是在其他非常成功的 COBRE/INBRE 计划的支持下建立的。特别是,
新资助的癌症免疫学和免疫治疗 COBRE 操作的功能免疫组学核心 (FIC)
同样由 Bodduluri 博士领导的机构与 FMC 开展了多项联合举措,包括建立一个
组织病理学服务中心。 FMC 将与这些和其他伦敦大学资源合作,以避免
设备重复,并对个别研究人员进行具体方案培训,促进创新方案
数据的开发和整合分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HARIBABU BODDULURI其他文献
HARIBABU BODDULURI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HARIBABU BODDULURI', 18)}}的其他基金
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
- 批准号:
8433515 - 财政年份:2009
- 资助金额:
$ 75.81万 - 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
- 批准号:
8015283 - 财政年份:2009
- 资助金额:
$ 75.81万 - 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
- 批准号:
8210894 - 财政年份:2009
- 资助金额:
$ 75.81万 - 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
- 批准号:
7635082 - 财政年份:2009
- 资助金额:
$ 75.81万 - 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
- 批准号:
7032234 - 财政年份:2003
- 资助金额:
$ 75.81万 - 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
- 批准号:
6706978 - 财政年份:2003
- 资助金额:
$ 75.81万 - 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
- 批准号:
6610703 - 财政年份:2003
- 资助金额:
$ 75.81万 - 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
- 批准号:
6858582 - 财政年份:2003
- 资助金额:
$ 75.81万 - 项目类别:
相似海外基金
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 75.81万 - 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 75.81万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 75.81万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 75.81万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 75.81万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 75.81万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 75.81万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 75.81万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 75.81万 - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
$ 75.81万 - 项目类别:














{{item.name}}会员




